Table 2.
Estimated daily sodium intake
| Age/years | #Recommended maximum total daily intake | All participants | Nonsalt losers | * Salt losers |
|---|---|---|---|---|
| 1–3 (N=39) | 1500 | 2180 (1690, 2805) | 2079 (1638, 2805) | 2180 (1719, 2702) |
| 4–8 (N=164) | 1900 | 2873 (2118, 4048) | 2623 (2039, 3946) | 3030 (2258, 4239) |
| 9–13 (N=235) | 2200 | 2937 (2244, 3678) | 2951 (2146, 3664) | 2921 (2321, 3690) |
| 14–18 (N=220) | 2300 | 3884 (2854, 5150) | 3847 (2803, 5051) | 4051 (2956, 5791) |
Intake amount was expressed in median (Interquartile range)
#
Adopted from Kidney Disease Outcomes Quality Initiative (KDOQI)1 and Kidney Disease: Improvig Global Outcomes (KDIGO)6 guidelines
*
Diagnoses for salt losers include obstructive uropathy, aplastic/hypoplastic/dysplastic kidneys, syndrome of agenesis of abdominal musculature, and congenital urologic disease (bilateral hydronephrosis)